×
About 11,418 results

ALLMedicine™ Ankylosing Spondylitis Center

Research & Reviews  3,034 results

Improving the design of RCTs in non-radiographic axial spondyloarthritis.
https://doi.org/10.1038/s41584-022-00789-1 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9 10.1001/jamanetworkopen.2022.2312 10.1136/annrheumdis-2012-201972 10.1136/rmdopen-2015-000057 10.1016/j.berh.2012.10.003 10.3899/jrheum.160079 10.1002/art.38738 10.1002/art.20990 10.1002/art.1780270401 10.1002/art.24483 10.1136/ard.2009.108233 10.1136/ard.2009.110767 10.1136/annrheumdis-2015-208642 10.3899/jrheum.161232 10.1136/ard.62.6.519 10.1055/s-2008-1067939 10.1136/annrheumdis-2014-205432 10.1136/annrheumdis-2019-215589 10.1002/art.38776 10.1136/ard.2008.097774 10.1002/art.23606 10.1136/ard.2010.139667 10.1002/art.24408 10.1136/annrheumdis-2012-201766 10.1002/art.21913 10.1136/annrheumdis-2012-202389 10.1136/annrheumdis-2015-207596 10.1002/art.20852 10.1136/annrheumdis-2013-204231 10.1002/art.40866 10.1002/art.23969 10.1002/art.41477 10.1016/S0140-6736(19)32971-X 10.1056/NEJMoa1505066 10.1016/S0140-6736(18)31946-9 10.1186/s13075-021-02650-4 10.1186/s13075-016-1093-z 10.1002/acr.22180 10.1136/annrheumdis-2020-217769 10.1002/art.40475 10.1002/art.40429 10.1093/rheumatology/kex491 10.1002/art.38721 10.1093/rheumatology/keab099 10.1002/art.41037 10.1002/acr.23244 10.1136/annrheumdis-2015-207823 10.1002/art.21445 10.3899/jrheum.140519 10.1038/nrrheum.2014.181
Nature Reviews. Rheumatology; Maksymowych WP, Lambert RGW et. al.

May 14th, 2022 - Concerns have been raised that randomized placebo-controlled trials (RCTs) in non-radiographic axial spondyloarthritis (nr-axSpA) might be failing to identify patients that best show differences in clinical response rates between those receiving a...

Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
https://clinicaltrials.gov/ct2/show/NCT02281747

May 13th, 2022 - Major orthopedic procedures, including total joint replacement and spine surgeries, are among the most common procedures in the population. Learning about how often these surgeries are performed can give indications of whether the treatment of art...

Natural History and Development of Spondyloarthritis
https://clinicaltrials.gov/ct2/show/NCT01422694

May 13th, 2022 - The purpose of this protocol is to study the natural history of spondyloarthritis (SpA) in children and adults. Spondyloarthritis encompasses a spectrum of immune-mediated inflammatory diseases that exhibit overlapping features, but differ from ot...

Editorial Expression of Concern: Breaking the diagnosis: ankylosing spondylitis evidenc...
https://doi.org/10.1007/s11739-022-02998-8 10.1212/WNL.0000000000013078
Internal and Emergency Medicine; Macêdo MB, Shinjo SK et. al.

May 11th, 2022 - Editorial Expression of Concern: Breaking the diagnosis: ankylosing spondylitis evidenced by cervical fracture following spine manipulation.|2022|Macêdo MB,Shinjo SK,Domiciano DS,|

Sex difference in disease burden of inflammatory arthritis patients treated with tumor ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071161
PloS One; Michelsen B, Berget KT et. al.

May 6th, 2022 - Knowledge is needed on the total disease burden across the sexes in inflammatory arthritis (IA). We aimed to compare disease burden, including a broad range of health aspects, across men and women with IA treated with tumor necrosis factor inhibit...

see more →

Guidelines  11 results

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.

Aug 23rd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients ...
https://www.ncbi.nlm.nih.gov/pubmed/30717501
Pain Physician; Kaye AD, Manchikanti L et. al.

Feb 6th, 2019 - Interventional pain management involves diagnosis and treatment of chronic pain. This specialty utilizes minimally invasive procedures to target therapeutics to the central nervous system and the spinal column. A subset of patients encountered in ...

The effectiveness, safety, and economic evaluation of Korean medicine for unexplained i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779787
Medicine

Mar 6th, 2018 - Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in 2012, but the evidence for these recommendations was only of indirect nature. These recommendations were re-evaluated in light of new insights. Based on the ...

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
https://doi.org/10.1136/annrheumdis-2016-210770
Annals of the Rheumatic Diseases; van der Heijde D, Ramiro S et. al.

Jan 15th, 2017 - To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one set applicable to the full spectrum of patients with...

EULAR recommendations for cardiovascular disease risk management in patients with rheum...
https://doi.org/10.1136/annrheumdis-2016-209775
Annals of the Rheumatic Diseases; Agca R, Heslinga SC et. al.

Oct 5th, 2016 - Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European League Against Rheumatism (EULAR) taskforce recommend...

see more →

Drugs  811 results see all →

Clinicaltrials.gov  132 results

Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
https://clinicaltrials.gov/ct2/show/NCT02281747

May 13th, 2022 - Major orthopedic procedures, including total joint replacement and spine surgeries, are among the most common procedures in the population. Learning about how often these surgeries are performed can give indications of whether the treatment of art...

Natural History and Development of Spondyloarthritis
https://clinicaltrials.gov/ct2/show/NCT01422694

May 13th, 2022 - The purpose of this protocol is to study the natural history of spondyloarthritis (SpA) in children and adults. Spondyloarthritis encompasses a spectrum of immune-mediated inflammatory diseases that exhibit overlapping features, but differ from ot...

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyl...
https://clinicaltrials.gov/ct2/show/NCT04436640

May 6th, 2022 - The purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA, also known as radiographic axSpa (r-axSpA)) including ankylosing spondylitis (AS) and...

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis
https://clinicaltrials.gov/ct2/show/NCT03928743

May 6th, 2022 - The purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active ankylosing spondylitis (AS).

2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis,...
https://clinicaltrials.gov/ct2/show/NCT05155098

Apr 29th, 2022 - After the baseline visit, data will be collected for each patient prospectively every 6 months for up to 2 years. At each visit, effectiveness parameters, as well as the patients' QoL and treatment pattern will be documented.

see more →

News  571 results

Upadacitinib Earns FDA Approval for Ankylosing Spondylitis 
https://www.medscape.com/viewarticle/973230

May 2nd, 2022 - The US Food and Drug Administration has approved upadacitinib (Rinvoq) as an oral treatment for active ankylosing spondylitis in adults, its manufacturer AbbVie announced April 29. Upadacitinib, a selective and reversible Janus kinase inhibitor, i...

IBD risk ‘uncertain’ in biologic-treated AxSpA patients
https://www.mdedge.com/rheumatology/article/254197/ankylosing-spondylitis/ibd-risk-uncertain-biologic-treated-axspa
Sara Freeman

Apr 28th, 2022 - Considerable uncertainty surrounds whether people with axial spondyloarthritis (axSpA) who are treated with biologic drugs have an increased risk for developing inflammatory bowel disease (IBD) that is higher than if they receive other treatments,.

IBD Risk 'Uncertain' in Biologic-Treated Patients With AxSpA
https://www.medscape.com/viewarticle/972907

Apr 28th, 2022 - Considerable uncertainty surrounds whether people with axial spondyloarthritis (axSpA) who are treated with biologic drugs have an increased risk for developing inflammatory bowel disease (IBD) that is higher than if they receive other treatments,...

Hypocaloric Diet Controls Joint Activity in Psoriatic Arthritis, Regardless of Weight Loss
https://www.medscape.com/viewarticle/972197

Apr 14th, 2022 - A 12-week hypocaloric diet provided suitable control of joint disease activity in patients with psoriatic arthritis (PsA), regardless of weight loss, Brazilian researchers found. Earlier research has reported that weight loss improves the symptoms...

TNF inhibitor treatment models promote personalized care in ankylosing spondylitis
https://www.mdedge.com/rheumatology/article/253636/ankylosing-spondylitis/tnf-inhibitor-treatment-models-promote
Heidi Splete

Apr 11th, 2022 - A small number of patient and physician-reported outcomes, as well as laboratory and clinical factors, may help to predict the response of patients with ankylosing spondylitis (AS) to treatment with tumor necrosis factor (TNF) inhibitors when they.

see more →

Patient Education  8 results see all →